What is a stock summary page? Click here for an overview.
Business Description
Assertio Holdings Inc
NAICS : 325412
SIC : 2834
ISIN : US2499081048
Compare
Compare
Traded in other countries / regions
ASRT.USA Index Membership
Russell 2000Russell 3000 IPO Date
1997-11-05Description
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.58 | |||||
| Equity-to-Asset | 0.43 | |||||
| Debt-to-Equity | 0.32 | |||||
| Debt-to-EBITDA | 5.57 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -2.47 | |||||
| Beneish M-Score | -3.13 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -20.1 | |||||
| 3-Year EBITDA Growth Rate | -55.9 | |||||
| 3-Year EPS without NRI Growth Rate | 2.9 | |||||
| 3-Year FCF Growth Rate | 29.7 | |||||
| 3-Year Book Growth Rate | -18 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 65.27 | |||||
| 9-Day RSI | 52.03 | |||||
| 14-Day RSI | 47.34 | |||||
| 3-1 Month Momentum % | -9.03 | |||||
| 6-1 Month Momentum % | -31.88 | |||||
| 12-1 Month Momentum % | -23.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.77 | |||||
| Quick Ratio | 1.43 | |||||
| Cash Ratio | 0.87 | |||||
| Days Inventory | 360.03 | |||||
| Days Sales Outstanding | 133.92 | |||||
| Days Payable | 134.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -28.9 | |||||
| Shareholder Yield % | -0.78 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.61 | |||||
| Operating Margin % | -15.03 | |||||
| Net Margin % | -17.27 | |||||
| FCF Margin % | 21.13 | |||||
| ROE % | -16.44 | |||||
| ROA % | -7.66 | |||||
| ROIC % | -17.53 | |||||
| 3-Year ROIIC % | 25.97 | |||||
| ROC (Joel Greenblatt) % | -633.02 | |||||
| ROCE % | -10.16 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 95.54 | |||||
| Price-to-Owner-Earnings | 7.62 | |||||
| PS Ratio | 0.55 | |||||
| PB Ratio | 0.6 | |||||
| Price-to-Tangible-Book | 1.76 | |||||
| Price-to-Free-Cash-Flow | 2.64 | |||||
| Price-to-Operating-Cash-Flow | 2.64 | |||||
| EV-to-EBIT | -0.49 | |||||
| EV-to-Forward-EBIT | 2.6 | |||||
| EV-to-EBITDA | 1.31 | |||||
| EV-to-Forward-EBITDA | 2.99 | |||||
| EV-to-Revenue | 0.07 | |||||
| EV-to-Forward-Revenue | 0.08 | |||||
| EV-to-FCF | 0.3 | |||||
| Price-to-GF-Value | 0.66 | |||||
| Price-to-Projected-FCF | 0.18 | |||||
| Price-to-Median-PS-Value | 0.59 | |||||
| Price-to-Net-Current-Asset-Value | 1.85 | |||||
| Earnings Yield (Greenblatt) % | -204.08 | |||||
| FCF Yield % | 36.44 | |||||
| Forward Rate of Return (Yacktman) % | 677.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ASRT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Assertio Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 124.96 | ||
| EPS (TTM) ($) | -0.23 | ||
| Beta | 0.79 | ||
| 3-Year Sharpe Ratio | -0.12 | ||
| 3-Year Sortino Ratio | -0.16 | ||
| Volatility % | 42.75 | ||
| 14-Day RSI | 47.34 | ||
| 14-Day ATR ($) | 0.038908 | ||
| 20-Day SMA ($) | 0.76022 | ||
| 12-1 Month Momentum % | -23.37 | ||
| 52-Week Range ($) | 0.6802 - 1.798 | ||
| Shares Outstanding (Mil) | 95.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Assertio Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Assertio Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Assertio Holdings Inc Frequently Asked Questions
What is Assertio Holdings Inc(ASRT)'s stock price today?
The current price of ASRT is $0.76. The 52 week high of ASRT is $1.80 and 52 week low is $0.68.
When is next earnings date of Assertio Holdings Inc(ASRT)?
The next earnings date of Assertio Holdings Inc(ASRT) is 2025-05-06 Est..
Does Assertio Holdings Inc(ASRT) pay dividends? If so, how much?
Assertio Holdings Inc(ASRT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers